BLUSF Recent News Escherichia Coli Infections - P
Post# of 7
Posted On: 03/03/2014 2:09:21 AM
BLUSF Recent News
Escherichia Coli Infections - Pipeline Review, H2 2013 M2 - Wed Nov 06, 2:30AM CST
Alzheon Launches with Veteran Team and Funding to Accelerate Drug Development in Alzheimer's Disease and Other Neurodegenerative Disorders Business Wire - Wed Oct 23, 5:00AM CDT
Thallion Pharmaceuticals Announces Cash Component of $0.1889 Per Share Marketwire - Fri Aug 09, 7:01AM CDT
Thallion Announces Shareholder Approval for Plan of Arrangement and Date and Time for the Motion for Final Court Order Marketwire - Tue Aug 06, 4:00PM CDT
RETRANSMISSION/Thallion Pharmaceuticals Announces Minimum Effective Net Cash of $7,500,000 Resulting in Cash Component of at Least $0.1765 Per Share Marketwire - Fri Aug 02, 9:54AM CDT
Thallion Pharmaceuticals Announces Minimum Effective Net Cash of $7,500,000 Resulting in Cash Component of at Least $0.1765 Per Share Marketwire - Fri Aug 02, 7:01AM CDT
Escherichia Coli Infections - Pipeline Review, H2 2013 M2 - Wed Nov 06, 2:30AM CST
Alzheon Launches with Veteran Team and Funding to Accelerate Drug Development in Alzheimer's Disease and Other Neurodegenerative Disorders Business Wire - Wed Oct 23, 5:00AM CDT
Thallion Pharmaceuticals Announces Cash Component of $0.1889 Per Share Marketwire - Fri Aug 09, 7:01AM CDT
Thallion Announces Shareholder Approval for Plan of Arrangement and Date and Time for the Motion for Final Court Order Marketwire - Tue Aug 06, 4:00PM CDT
RETRANSMISSION/Thallion Pharmaceuticals Announces Minimum Effective Net Cash of $7,500,000 Resulting in Cash Component of at Least $0.1765 Per Share Marketwire - Fri Aug 02, 9:54AM CDT
Thallion Pharmaceuticals Announces Minimum Effective Net Cash of $7,500,000 Resulting in Cash Component of at Least $0.1765 Per Share Marketwire - Fri Aug 02, 7:01AM CDT
(0)
(0)